Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial, page-18

I am still fairly new to FTT and have read about the past trial. Have I got it right - that the trial was a success yet the company incorrectly structured it as a device and not a drug so it was useless in a commercial sense?

Also the treated patients were compared to another study of "best practice' so there was some ambiguity there? (no placebo group)

Probably worded my question a little wrong but I hope you get what I mean...